Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Anticancer Research|June 10, 2010
Cyclin D1b in human breast carcinoma and coexpression with cyclin D1a is associated with poor outcomeVandana Gupta Abramson, Andrea B Troxel, Michael Feldman, et al.Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 21, 2005
Serum concentrations of estrogens, sex hormone binding globulin, and androgens and risk of breast hyperplasia in postmenopausal womenCatherine Schairer, Deirdre Hill, Susan R Sturgeon, et al.Journal of Surgical Oncology|June 5, 2020
Molecular characterization of breast cancer needle core biopsy specimens by the 21-gene Breast Recurrence Score testDebbie M Jakubowski, Helen Bailey, John Abran, et al.International Journal of Cancer|August 9, 2006
Serum concentrations of estrogens, sex hormone-binding globulin, and androgens and risk of breast cancer in postmenopausal womenLaila Adly, Deirdre Hill, Mark E Sherman, et al.International Journal of Cancer|December 30, 2003
Serum concentrations of IGF-I, IGFBP-3 and c-peptide and risk of hyperplasia and cancer of the breast in postmenopausal womenCatherine Schairer, Deirdre Hill, Susan R Sturgeon, et al.Radiology|March 14, 2014
Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility studyShannon C Agner, Mark A Rosen, Sarah Englander, et al.Human Pathology|October 1, 2013
Fibroblast activation protein expression by stromal cells and tumor-associated macrophages in human breast cancerJulia Tchou, Paul J Zhang, Yingtao Bi, et al.Biomedical Optics Express|January 11, 2013
Optical malignancy parameters for monitoring progression of breast cancer neoadjuvant chemotherapyDavid R Busch, Regine Choe, Mark A Rosen, et al.Medical Physics|May 7, 2010
Computer aided automatic detection of malignant lesions in diffuse optical mammographyDavid R Busch, Wensheng Guo, Regine Choe, et al.Breast Cancer Research and Treatment|June 4, 2017
Comparison of residual cancer burden, American Joint Committee on Cancer staging and pathologic complete response in breast cancer after neoadjuvant chemotherapy: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)Jeffrey I Campbell, Christina Yau, Polina Krass, et al.Pageof 4